Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001683168-25-003496
Filing Date
2025-05-13
Accepted
2025-05-13 17:00:16
Documents
44
Period of Report
2025-03-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q FOR MAR 2025 xenetic_i10q-33125.htm   iXBRL 10-Q 381029
2 CERTIFICATION xenetic_ex3101.htm EX-31.1 9109
3 CERTIFICATION xenetic_ex3102.htm EX-31.2 9227
4 CERTIFICATION xenetic_ex3201.htm EX-32.1 3880
  Complete submission text file 0001683168-25-003496.txt   2154622

Data Files

Seq Description Document Type Size
5 XBRL SCHEMA FILE xbio-20250331.xsd EX-101.SCH 17931
6 XBRL CALCULATION FILE xbio-20250331_cal.xml EX-101.CAL 24181
7 XBRL DEFINITION FILE xbio-20250331_def.xml EX-101.DEF 72097
8 XBRL LABEL FILE xbio-20250331_lab.xml EX-101.LAB 149281
9 XBRL PRESENTATION FILE xbio-20250331_pre.xml EX-101.PRE 120230
46 EXTRACTED XBRL INSTANCE DOCUMENT xenetic_i10q-33125_htm.xml XML 190086
Mailing Address 945 CONCORD ST. FRAMINGHAM MA 01701
Business Address 945 CONCORD ST. FRAMINGHAM MA 01701 781-778-7720
Xenetic Biosciences, Inc. (Filer) CIK: 0001534525 (see all company filings)

EIN.: 452952962 | State of Incorp.: NV | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-37937 | Film No.: 25941114
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)